0QNA fundamentals
BASILEA PHARMACEUTICA AG ALLSCHWIL CHF1 (REGD) financial statements, including revenue, expenses, profit, and loss
The total revenue of 0QNA for the last semiannual is 72.73 M CHF, and it's 14.34% lower compared to the previous semiannual. The net income of H2 23 is -21.39 M CHF.
0.00
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: CHF
TTM